Ratings changes for Healthcare Services Group, XOMA, Super Micro Computer, Fluence Energy, Qurate Retail, Cyclacel Pharmaceuticals, Moderna and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

February 11th, 2025

Elon's Favorite Energy Source Is Incredibly Undervalued-It Trades for Just 40 Cents (ad)

Elon Musk has a bold vision: a future where his favorite energy source powers the world. And he's not alone. Amazon, Google, Meta, and Microsoft are driving 40% of U.S. demand, signaling that it's the future.

And the reason why? AI is set to increase global energy consumption by up to 10x, and this energy source is the only one that can meet the demand.

Right now is a unique chance to witness this explosive growth for less than 40 cents.

Reveal This Historic Opportunity Now

Today's Top Stories

3 Reasons to Love This Underperforming Chipmaker

By Sam Quirke | February 10, 2025 08:42 AM

The last time this happened a lucky trader made a rare 1,150% (Ad)

By Wealthpin Pro

Coca-Cola reverses sales volume slide, sending revenue up 6% in the fourth quarter

By The Associated Press | February 11, 2025 06:09 AM

Why Salesforce Stock Could Be on the Verge of a Breakout

By Sam Quirke | February 10, 2025 09:12 AM

“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

By Weiss Ratings

Iran loosens import restrictions on foreign cars and iPhones, trying to mask its economic woes

By The Associated Press | February 10, 2025 11:13 PM

3 Construction Stocks Set to Surge on Tariff-Driven Demand

By Gabriel Osorio-Mazilli | February 11, 2025 07:45 AM

Quick Links

MarketBeat All Access

A deadly mistake in my prediction… (ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.

Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Your Watchlist

You have not added any stocks to your watchlist.

Click here to add stocks to your watchlist

Analysts' Upgrades

Allient (NASDAQ:ALNT) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $30.00. This represents a 34.6% upside from the current price of $26.01.

Brixmor Property Group (NYSE:BRX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $31.00 price target on the stock. This represents a 15.5% upside from the current price of $26.83.

Compass (NYSE:COMP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $11.00 price target on the stock, up previously from $7.00. This represents a 41.8% upside from the current price of $7.76.

First Solar (NASDAQ:FSLR) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $259.00 price target on the stock, up previously from $218.00. This represents a 58.1% upside from the current price of $163.82.

Southwest Airlines (NYSE:LUV) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock. This represents a 16.7% upside from the current price of $30.00.

monday.com (NASDAQ:MNDY) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $420.00 price target on the stock. This represents a 27.1% upside from the current price of $330.48.

Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. This represents a 72.0% upside from the current price of $8.72.

RTX (NYSE:RTX) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.The current price is $128.35.

Super Micro Computer (NASDAQ:SMCI) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. They now have a $48.00 price target on the stock. This represents a 15.0% upside from the current price of $41.75.

Steel Dynamics (NASDAQ:STLD) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $155.00 price target on the stock. This represents a 15.8% upside from the current price of $133.88.

TXNM Energy (NYSE:TXNM) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $54.00 price target on the stock, up previously from $51.00. This represents a 10.1% upside from the current price of $49.07.

View More Upgrades

Collect $7k per month from Tesla’s SECRET dividend (ad)

Tesla doesn't pay a traditional dividend....

But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla…

Which could put up to $7,013 in your pocket every month…

Click here to discover the new #1 way to invest in Tesla

Analysts' Downgrades

Columbus McKinnon (NASDAQ:CMCO) was downgraded by analysts at DA Davidson from a "buy" rating to a "neutral" rating. They now have a $35.00 price target on the stock. This represents a 57.0% upside from the current price of $22.29.

Dynavax Technologies (NASDAQ:DVAX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $12.00 price target on the stock, down previously from $15.00. This represents a 3.1% downside from the current price of $12.38.

Equifax (NYSE:EFX) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $250.67.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Guggenheim from a "buy" rating to a "sell" rating. They now have a $6.00 price target on the stock, down previously from $26.00. This represents a 12.8% downside from the current price of $6.88.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $10.00 price target on the stock, down previously from $22.00. This represents a 45.4% upside from the current price of $6.88.

First National (NASDAQ:FXNC) was downgraded by analysts at Hovde Group from an "outperform" rating to a "market perform" rating. They now have a $28.50 price target on the stock. This represents a 9.1% upside from the current price of $26.13.

Cloudflare (NYSE:NET) was downgraded by analysts at DZ Bank AG from a "hold" rating to a "sell" rating. They now have a $145.00 price target on the stock. This represents a 15.1% downside from the current price of $170.83.

Playa Hotels & Resorts (NASDAQ:PLYA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $13.50 price target on the stock, down previously from $15.00. This represents a 1.8% upside from the current price of $13.26.

Playa Hotels & Resorts (NASDAQ:PLYA) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $13.26.

Q32 Bio (NASDAQ:QTTB) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $4.00 price target on the stock, down previously from $20.00. This represents a 37.5% upside from the current price of $2.91.

Q32 Bio (NASDAQ:QTTB) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $3.00 price target on the stock, down previously from $22.00. This represents a 3.1% upside from the current price of $2.91.

REGENXBIO (NASDAQ:RGNX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $14.00 price target on the stock, down previously from $38.00. This represents a 89.7% upside from the current price of $7.38.

Snap (NYSE:SNAP) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $10.61.

TechTarget (NASDAQ:TTGT) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $17.04.

View More Downgrades

We recommended Palantir in 2021, now we’re recommending this... (ad)

I believe it could offer you a MAJOR boost to your retirement.

And it pays huge dividends to give you a nice stream of income along the way.

Our research indicates ONE AI stock is poised to benefit the most.

Analysts' New Coverage

ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $22.00 price target on the stock. This represents a 19.6% upside from the current price of $18.39.

Alkermes (NASDAQ:ALKS) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $40.00 price target on the stock. This represents a 27.4% upside from the current price of $31.40.

Avadel Pharmaceuticals (NASDAQ:AVDL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $12.00 price target on the stock. This represents a 34.8% upside from the current price of $8.90.

Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $176.00 price target on the stock. This represents a 31.5% upside from the current price of $133.81.

AZZ (NYSE:AZZ) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $108.00 price target on the stock. This represents a 11.2% upside from the current price of $97.12.

Biohaven (NYSE:BHVN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $65.00 price target on the stock. This represents a 60.3% upside from the current price of $40.54.

Biogen (NASDAQ:BIIB) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $160.00 price target on the stock. This represents a 13.9% upside from the current price of $140.42.

Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.The current price is $35.84.

Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $31.00 price target on the stock. This represents a 46.7% upside from the current price of $21.13.

Domo (NASDAQ:DOMO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $11.00 price target on the stock. This represents a 20.0% upside from the current price of $9.17.

ECARX (NASDAQ:ECX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $3.20 price target on the stock. This represents a 65.4% upside from the current price of $1.94.

Flex (NASDAQ:FLEX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $52.00 price target on the stock. This represents a 20.4% upside from the current price of $43.19.

Gaia (NASDAQ:GAIA) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $10.00 price target on the stock. This represents a 89.8% upside from the current price of $5.27.

Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $55.00 price target on the stock. This represents a 44.5% upside from the current price of $38.07.

International Business Machines (NYSE:IBM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $320.00 price target on the stock. This represents a 27.2% upside from the current price of $251.61.

Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $138.00 price target on the stock. This represents a 19.4% upside from the current price of $115.59.

Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $111.00 price target on the stock. This represents a 37.6% upside from the current price of $80.69.

Silence Therapeutics (NASDAQ:SLN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $6.00 price target on the stock. This represents a 34.6% upside from the current price of $4.46.

Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $136.00 price target on the stock. This represents a 22.6% upside from the current price of $110.96.

Sunrise Realty Trust (NASDAQ:SUNS) is now covered by analysts at Keefe, Bruyette & Woods. They set an "outperform" rating and a $12.75 price target on the stock. This represents a 9.3% upside from the current price of $11.66.

TTM Technologies (NASDAQ:TTMI) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $33.00 price target on the stock. This represents a 23.9% upside from the current price of $26.64.

Waystar (NASDAQ:WAY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $51.00 price target on the stock. This represents a 22.3% upside from the current price of $41.69.

Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $67.00 price target on the stock. This represents a 73.0% upside from the current price of $38.73.

View More New Coverage

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial